Alexandre Chlenski to Cell Movement
This is a "connection" page, showing publications Alexandre Chlenski has written about Cell Movement.
Connection Strength
0.367
-
Secreted protein acidic and rich in cysteine (SPARC) induces lipotoxicity in neuroblastoma by regulating transport of albumin complexed with fatty acids. Oncotarget. 2016 Nov 22; 7(47):77696-77706.
Score: 0.112
-
Anti-angiogenic SPARC peptides inhibit progression of neuroblastoma tumors. Mol Cancer. 2010 Jun 04; 9:138.
Score: 0.071
-
SPARC enhances tumor stroma formation and prevents fibroblast activation. Oncogene. 2007 Jul 05; 26(31):4513-22.
Score: 0.057
-
Neuroblastoma angiogenesis is inhibited with a folded synthetic molecule corresponding to the epidermal growth factor-like module of the follistatin domain of SPARC. Cancer Res. 2004 Oct 15; 64(20):7420-5.
Score: 0.048
-
SPARC is a key Schwannian-derived inhibitor controlling neuroblastoma tumor angiogenesis. Cancer Res. 2002 Dec 15; 62(24):7357-63.
Score: 0.043
-
Histone-lysine methyltransferase EHMT2 is involved in proliferation, apoptosis, cell invasion, and DNA methylation of human neuroblastoma cells. Anticancer Drugs. 2013 Jun; 24(5):484-93.
Score: 0.022
-
Thrombospondin-1 peptide ABT-510 combined with valproic acid is an effective antiangiogenesis strategy in neuroblastoma. Cancer Res. 2007 Feb 15; 67(4):1716-24.
Score: 0.014